Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Yield stocks
Momentum stocks
Trend-Following Stocks
Undervalued stocks
Growth stocks
ESG stocks
Investment Themes
Strategic Metals
Cybersecurity
The Vegan Market
In Vino Veritas
Luxury
Gold and Silver
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
In Vino Veritas
Education
Boats
Water
Artificial Intelligence
Hydrogen
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
Our subscriptions
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
United States
Nasdaq
Mereo BioPharma Group plc
News
Summary
MREO
US5894921072
MEREO BIOPHARMA GROUP PLC
(MREO)
Add to my list
Report
Delayed Nasdaq -
04:00 2022-08-08 pm EDT
1.180
USD
-8.53%
11:08a
European ADRs Move Higher in Monday Trading
MT
08/05
European ADRs Move Lower in Friday Trading
MT
08/01
European ADRs Move Higher in Monday Trading
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
European ADRs Move Lower in Friday Trading
06/17/2022 | 11:09am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
© MT Newswires 2022
Stocks mentioned in the article
Change
Last
1st jan.
ADAPTIMMUNE THERAPEUTICS PLC
-5.13%
2.22
-37.60%
ARGENX SE
-0.06%
360
14.24%
AVADEL PHARMACEUTICALS PLC
7.31%
6.31
-27.23%
BHP GROUP LIMITED
0.80%
39.12
-6.48%
BICYCLE THERAPEUTICS PLC
5.53%
27.65
-56.96%
BP PLC
1.25%
416.3
24.40%
CELLECTIS S.A.
8.87%
3.56
-56.05%
DBV TECHNOLOGIES
3.42%
5.29
67.21%
ENI SPA
-0.09%
11.446
-6.25%
ERYTECH PHARMA S.A.
0.66%
1.218
-42.92%
HSBC HOLDINGS PLC
0.66%
545.5
20.78%
LONDON BRENT OIL
2.51%
96.21
21.13%
MEREO BIOPHARMA GROUP PLC
-8.53%
1.18
-19.38%
MORPHOSYS AG
0.13%
22.46
-32.74%
SHELL PLC
0.53%
2161.5
32.57%
TOTALENERGIES SE
1.90%
49.82
9.55%
WTI
2.76%
90.405
17.49%
ZEALAND PHARMA A/S
-1.86%
126.8
-10.96%
All news about MEREO BIOPHARMA GROUP PLC
11:08a
European ADRs Move Higher in Monday Trading
MT
08/05
European ADRs Move Lower in Friday Trading
MT
08/01
European ADRs Move Higher in Monday Trading
MT
07/29
European ADRs Move Higher in Friday Trading
MT
07/27
European ADRs Move Higher in Wednesday Trading
MT
07/25
European ADRs Move Higher in Monday Trading
MT
07/21
European ADRs Nudge Higher in Thursday Trading
MT
07/20
European ADRs Move Lower in Wednesday Trading
MT
07/19
European ADRs Rise in Tuesday Trading
MT
07/12
European ADRs Move Lower in Tuesday Trading
MT
More news
Analyst Recommendations on MEREO BIOPHARMA GROUP PLC
06/06
Needham Adjusts Price Target on Mereo BioPharma Group to $5 From $10, Reiterates Buy Ra..
MT
2021
MEREO BIOPHARMA
: BTIG Initiates Mereo BioPharma at Buy Rating With $10 Price Target
MT
2021
MEREO BIOPHARMA
: Needham Starts Mereo BioPharma Group at Buy With $10 Price Target
MT
More recommendations
Financials
GBP
USD
Sales 2022
-
-
-
Net income 2022
-39,7 M
-47,8 M
-47,8 M
Net cash 2022
32,5 M
39,1 M
39,1 M
P/E ratio 2022
-14,6x
Yield 2022
-
Capitalization
116 M
140 M
140 M
EV / Sales 2022
-
EV / Sales 2023
8,92x
Nbr of Employees
49
Free-Float
51,6%
More Financials
Chart MEREO BIOPHARMA GROUP PLC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends MEREO BIOPHARMA GROUP PLC
Short Term
Mid-Term
Long Term
Trends
Neutral
Bullish
Neutral
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
107,10 GBX
Average target price
562,57 GBX
Spread / Average Target
425%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
Denise Vera Scots-Knight
Chief Executive Officer & Director
Christine Fox
Chief Financial Officer
Michael S. Wyzga
Chairman
John A. Lewicki
Chief Scientific Officer
Suba Krishnan
Senior Vice President-Clinical Development
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
MEREO BIOPHARMA GROUP PLC
-19.38%
140
GILEAD SCIENCES, INC.
-15.87%
76 626
VERTEX PHARMACEUTICALS
31.16%
73 868
REGENERON PHARMACEUTICALS, INC.
-2.84%
65 600
BIONTECH SE
-28.97%
44 499
WUXI APPTEC CO., LTD.
-20.64%
41 093
More Results
Slave